google-site-verification=hWHA3xrHlb9JWqZAvhDuHoCP2p6eVDDbBVmibK__gNc
Welcome to Tacoma Vet Medications

BURVAQUIN

$45.00

BURVAQUIN Injectable Solution is an FDA-approved antibiotic specifically designed for the treatment of lower respiratory tract infections in horses. Let’s delve into the details:

    • Indication and Target Pathogen:
      • BURVAQUIN is indicated for treating infections caused by Streptococcus equi subspecies zooepidemicus (S. zooepidemicus).
      • S. zooepidemicus is a common pathogen associated with equine respiratory infections.
    • Mechanism of Action:
      • BURVAQUIN contains ceftiofur crystalline free acid, a broad-spectrum cephalosporin antibiotic.
      • It acts by inhibiting bacterial cell wall synthesis, effectively targeting both gram-positive and gram-negative bacteria.
    • Sustained-Release Advantage:
      • BURVAQUIN is the first and only sustained-release antibiotic approved for horses.
      • With just two treatments, it provides a full 10-day course of therapy.
      • This dosing schedule enhances compliance and convenience for horse owners and veterinarians.
    • Effective Relief and Rapid Action:
      • Horses respond rapidly to BURVAQUIN, experiencing relief within 5–10 minutes.
      • Most achieve relief from colic spasms within 30 minutes.
      • Fewer administrations reduce the risk of missed doses compared to daily treatments.
    • Safety Considerations:
      • Avoid BURVAQUIN use in impaction colics associated with ileus or in horses with glaucoma.
      • Transient elevated heart rate is a common side effect post-injection.
    • Overall Benefit:
      • BURVAQUIN effectively manages respiratory infections, allowing horses to recover comfortably.

Reviews

There are no reviews yet.

Be the first to review “BURVAQUIN”

Your email address will not be published. Required fields are marked *

You cannot copy content of this page

Cart

Your Cart is Empty

Back To Shop